Literature DB >> 28931894

Factors Generating Glucose Degradation Products In Sterile Glucose Solutions For Infusion: Statistical Relevance Determination Of Their Impacts.

J Haybrard1,2, N Simon3,4, C Danel2, C Pinçon5, C Barthélémy2, F J Tessier6, B Décaudin1,2, E Boulanger6, P Odou1,2.   

Abstract

Sterilising glucose solutions by heat promotes the generation of a large number of glucose degradation products (GDPs). It has been shown that high levels of GDPs may result in Advanced Glycation End products that have an impact on cellular homeostasis and health in general. If data is available for peritoneal dialysis solutions, little has been published for glucose infusion fluids. It is essential to identify the parameters causing the formation of GDPs and so limit the risk of exposing patients to them. After quantifying both 5-hydroxymethyl-2-furfural, considered as an important indicator of degradation, and 2-furaldehyde, an ultimate GDP of one degradation pathway, in marketed solutions, the aim of this work is to build a model integrating all the parameters involved in the formation rates of these two GDPs: supplier, glucose amount, container material, oxygen permeability coefficient and time-lapse since manufacture. Our results show a good logarithmic relationship between GDP formation rates and time-lapse since manufacture for both GDPs. The amount of GDPs in the glucose solutions for infusion depends on the initial glucose amount, the polymer of the container, the time elapsed since manufacturing and the supplier.

Entities:  

Year:  2017        PMID: 28931894      PMCID: PMC5607278          DOI: 10.1038/s41598-017-12296-5

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  38 in total

1.  Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose.

Authors:  P J Thornalley; A Langborg; H S Minhas
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

Review 2.  Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases.

Authors:  Stylianos A Kandarakis; Christina Piperi; Fotis Topouzis; Athanasios G Papavassiliou
Journal:  Prog Retin Eye Res       Date:  2014-06-04       Impact factor: 21.198

3.  Baseline serum interleukin-6 predicts cardiovascular events in incident peritoneal dialysis patients.

Authors:  Yeoungjee Cho; David W Johnson; David A Vesey; Carmel M Hawley; Elaine M Pascoe; Margaret Clarke; Nicholas Topley
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

4.  The impact of preoperative micronutrient supplementation in lung surgery. A prospective randomized trial of oral supplementation of combined alpha-ketoglutaric acid and 5-hydroxymethylfurfural.

Authors:  Veronika Matzi; Joerg Lindenmann; Andreas Muench; Joachim Greilberger; Heinz Juan; Reinhard Wintersteiger; Alfred Maier; Freyja Maria Smolle-Juettner
Journal:  Eur J Cardiothorac Surg       Date:  2007-09-04       Impact factor: 4.191

5.  3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis.

Authors:  Marina Penélope Catalan; Beatriz Santamaría; Ana Reyero; Arturo Ortiz; Jesús Egido; Alberto Ortiz
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

6.  Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure.

Authors:  S Müller-Krebs; L P Kihm; B Zeier; M L Gross; R Deppisch; A Wieslander; T Henle; I Penndorf; J Oh; J Reiser; P P Nawroth; M Zeier; V Schwenger
Journal:  Eur J Clin Invest       Date:  2008-03-16       Impact factor: 4.686

7.  The effect of low-GDP solution on ultrafiltration and solute transport in continuous ambulatory peritoneal dialysis patients.

Authors:  Kyu-Hyang Cho; Jun-Young Do; Jong-Won Park; Kyung-Woo Yoon; Yong-Lim Kim
Journal:  Perit Dial Int       Date:  2013-01-02       Impact factor: 1.756

Review 8.  Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis.

Authors:  Elvia García-López; Juan J Carrero; Mohamed E Suliman; Bengt Lindholm; Peter Stenvinkel
Journal:  Perit Dial Int       Date:  2007-06       Impact factor: 1.756

9.  The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.

Authors:  Eric Boulanger; Marie-Paule Wautier; Pierre Gane; Christophe Mariette; Olivier Devuyst; Jean-Luc Wautier
Journal:  Nephrol Dial Transplant       Date:  2004-06-22       Impact factor: 5.992

Review 10.  A review of 5-hydroxymethylfurfural (HMF) in parenteral solutions.

Authors:  R J Ulbricht; S J Northup; J A Thomas
Journal:  Fundam Appl Toxicol       Date:  1984-10
View more
  5 in total

Review 1.  The role of endogenous versus exogenous sources in the exposome of putative genotoxins and consequences for risk assessment.

Authors:  Ivonne M C M Rietjens; Arand Michael; Hermann M Bolt; Bourdoux Siméon; Hartwig Andrea; Hinrichsen Nils; Kalisch Christine; Mally Angela; Pellegrino Gloria; Ribera Daniel; Thatcher Natalie; Eisenbrand Gerhard
Journal:  Arch Toxicol       Date:  2022-03-06       Impact factor: 6.168

2.  Metal cations promote α-dicarbonyl formation in glucose-containing peritoneal dialysis fluids.

Authors:  Sabrina Gensberger-Reigl; Andrea Auditore; Jochen Huppert; Monika Pischetsrieder
Journal:  Glycoconj J       Date:  2020-12-07       Impact factor: 2.916

3.  The Effect of Far-Infrared Therapy on the Peritoneal Expression of Glucose Degradation Products in Diabetic Patients on Peritoneal Dialysis.

Authors:  Chia-Ning Chang; Chih-Yuan Niu; Ann Charis Tan; Chia-Hao Chan; Chun-Fan Chen; Tz-Heng Chen; Szu-Yuan Li; Yung-Tai Chen; Fan-Yu Chen; Wen-Sheng Liu; Chih-Ching Lin; Guor-Jien Wei
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

Review 4.  PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.

Authors:  Domonkos Pap; Apor Veres-Székely; Beáta Szebeni; Ádám Vannay
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

5.  Identification and quantification of glucose degradation products in heat-sterilized glucose solutions for parenteral use by thin-layer chromatography.

Authors:  Sarah Leitzen; Matthias Vogel; Anette Engels; Thomas Zapf; Martin Brandl
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.